|
|
|
CYP Catalog: Needle-Free Jet InjectorsUse of Needle-Free Anesthesia in the Treatment of Palmar HHUse of needle-free anesthesia in the treatment of palmar hyperhidrosis with botulinum A toxin. by Antranik Benohanian, MD, FRCPC. Montreal, Quebec, Canada. From the Division of Dermatology, Department of Medicine, University of Montreal. Journal of American Academy of Dermatology, 2005, 52:1073. Botulinum toxin type A (BTX-A) is a useful treatment for palmar hyperhidrosis [1], especially when conservative measures fail. However, palmar injection of BTX-A with a needle is painful. The standard method of analgesia, nerve block of the wrist, has potential drawbacks: vascular puncture, impaired hand dexterity, and nerve scarring from repeated injuries [2]. Alternative analgesia consists of a standard skin wheal of local anesthetic raised on the palms with a needle, but it may also be painful. Because jet injection of local anesthetic reduces pain [3], needle-free lidocaine injections prior to BTX-A injections (with a needle) are a reasonable option. (Reconstitution of BTX-A with lidocaine does not jeopardize toxin potency [4].) TECHNIQUE The technique is easy to perform, quick, and welltolerated. Map out the BTX-A injection sites on the palm. Prepare the needle-free injector (MED-JET; Medical International Technologies Canada, Montreal, Quebec, Canada; Fig 1) by adjusting the volume per spurt to 0.02 mL (range, 0.01-0.1 mL) and adjusting the pressure system so that the injection reaches the desired depth. Use the MED-JET to produce superficial skin wheals of lidocaine 2% over the entire palmar surface, 1.5 cm to 2 cmapart (Fig 2). Then inject BTX-A with a 31-gauge needle. The metal component of the MED-JET requires sterilization at 1348C with an autoclave for 30 minutes; the plastic component undergoes only cold sterilization. Side effects include small bruises (of about 1 mm) that fade after a few weeks (Fig 3). The cost of a MED-JET unit is $5000 (US). In conclusion, this technique has the potential to replace peripheral nerve blockade prior to BTX-A injections for the treatment of palmar hyperhidrosis. It may also be used for plantar hyperhidrosis.
Fig 1. Needle-free injector. The MED-JET MBX model is produced by Medical International Technologies Inc (Montreal, Quebec, Canada), a subsidiary of Medical International Technology USA.
Fig 2. Lidocaine injection sites 1.5 cm to 2 cm apart.
Fig 3. Minor bruising shown 24 hours after injections. REFERENCES:
Funding sources: Allergan Inc. provided editorial assistance. Conflicts of interest: None identified. Reprint requests and correspondence: Antranik Benohanian, MD, Centre Hospitalier de l’Université de Montréal, 1058 Rue Saint-Denis, Montréal, QC, H2X 3J4, Canada. E-mail: info@benohanian.com. For this section, you can select from one of the following: Principle of Operation (Agro-Jet® or Med-Jet®), Slideshows, Brochures, Videos, Cost Effectiveness Calculator, Answers to Frequently Asked Questions, References, and Warranty information. For information on specific products, select either Veterinary Products for animal applications or Medical Products for human applications. |
|
|
|